Sfoglia per AUTORE
SOLAROLI C
Collezione ASL Torino 4
Items : 2
Tildrakizumab and Quality of Life: Deep Dive into the Impact of Psoriasis and Treatment on Different Domains-Should Psychosocial Life Impairment Be Considered a Comorbidity? in Journal of clinical medicine / J Clin Med. 2025 Jan 2;14(1):223. doi: 10.3390/jcm14010223.
2025
ASL Torino 4
ASL Torino 4
Licata G; Di Brizzi EV; Castelli F; Giuffrida G; Stroppiana E; Dattola A; Richetta AG; De Col E; Peila R; Siliquini N; Solaroli C; Zanetta R; Cerulli E; Galdo G; Giordano D; Faure E; Papaianni V; Pertusi G; Uzzauto MT; Loconsole F; Zichichi L;
Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e838-e841. doi: 10.1111/jdv.18314. Epub 2022 Jun 22.
2022
ASL Biella
ASL Asti
AOU Alessandria
ASL Alessandria
ASL Torino 4
ASL Biella
ASL Asti
AOU Alessandria
ASL Alessandria
ASL Torino 4
Passerini SG; Macagno N; Cariti C; Licciardello M; Solaroli C; Pertusi G; Aragone MG; Baggini G; Addese C; Leporati C; Peila R; Giura MT; Rossotto G; Pella P; Mocci L; Merlo G; Tiberio R; Graziola F; Quaglino P; Dapavo P; Ribero S; Ortoncelli M; Susca S; Boskovic S; Stroppiana E; Mastorino L; Verrone A; Castelli F;